Khristofer Garcia

1.1k total citations
13 papers, 792 citations indexed

About

Khristofer Garcia is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Khristofer Garcia has authored 13 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Khristofer Garcia's work include Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (4 papers) and Multiple Myeloma Research and Treatments (2 papers). Khristofer Garcia is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (4 papers) and Multiple Myeloma Research and Treatments (2 papers). Khristofer Garcia collaborates with scholars based in United States, Japan and France. Khristofer Garcia's co-authors include Jonathan L. Blank, Paul Hales, Paul Fleming, Lawrence R. Dick, Frank J. Bruzzese, Christopher Tsu, Erik Kupperman, Li Yu, Jie Yu and Mark Manfredi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Khristofer Garcia

13 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khristofer Garcia United States 8 696 359 208 60 56 13 792
Tina M. Woo United States 7 620 0.9× 269 0.7× 380 1.8× 51 0.8× 28 0.5× 13 751
John S. Strader United States 4 582 0.8× 275 0.8× 384 1.8× 42 0.7× 22 0.4× 7 706
Kanda Sangthongpitag Singapore 15 629 0.9× 245 0.7× 72 0.3× 35 0.6× 76 1.4× 25 827
Mariël Brok Netherlands 13 531 0.8× 323 0.9× 232 1.1× 28 0.5× 27 0.5× 14 951
Bret Bannerman United States 5 406 0.6× 214 0.6× 195 0.9× 33 0.6× 41 0.7× 9 515
Amy Cruickshank United Kingdom 2 430 0.6× 210 0.6× 104 0.5× 45 0.8× 109 1.9× 3 556
Tracy Keates United Kingdom 7 1.6k 2.3× 222 0.6× 496 2.4× 41 0.7× 72 1.3× 7 1.7k
Luis A. Carvajal United States 10 550 0.8× 354 1.0× 92 0.4× 35 0.6× 40 0.7× 29 814
Teresa A. Soucy United States 6 668 1.0× 321 0.9× 71 0.3× 98 1.6× 19 0.3× 8 745
Soraya Wuillème‐Toumi France 5 467 0.7× 151 0.4× 230 1.1× 37 0.6× 19 0.3× 6 553

Countries citing papers authored by Khristofer Garcia

Since Specialization
Citations

This map shows the geographic impact of Khristofer Garcia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khristofer Garcia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khristofer Garcia more than expected).

Fields of papers citing papers by Khristofer Garcia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khristofer Garcia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khristofer Garcia. The network helps show where Khristofer Garcia may publish in the future.

Co-authorship network of co-authors of Khristofer Garcia

This figure shows the co-authorship network connecting the top 25 collaborators of Khristofer Garcia. A scholar is included among the top collaborators of Khristofer Garcia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khristofer Garcia. Khristofer Garcia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lee, Ho‐Young, Ames C. Register, Kathleen Abadie, et al.. (2019). Development of a bioassay to detect T-cell-activating impurities for T-cell-dependent bispecific antibodies. Scientific Reports. 9(1). 3900–3900. 12 indexed citations
2.
Bouck, David C., Khristofer Garcia, Jonathan L. Blank, et al.. (2015). Abstract C55: Nedd8-activating enzyme inhibitor pevonedistat synergizes with cisplatin and carboplatin through interference with nucleotide excision repair and interstrand cross-link repair mechanisms in non-small cell lung cancer. Molecular Cancer Therapeutics. 14(12_Supplement_2). C55–C55. 1 indexed citations
3.
Garcia, Khristofer, Jonathan L. Blank, David C. Bouck, et al.. (2014). Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways. Molecular Cancer Therapeutics. 13(6). 1625–1635. 45 indexed citations
5.
Zhang, Julie, Jerome T. Mettetal, Kazuhide Nakamura, et al.. (2013). Use of combination treatment with the investigational RAF kinase inhibitor MLN2480 and the investigational MEK kinase inhibitor TAK-733 on the growth of BRAF-mutant and RAS-mutant preclinical models of melanoma and CRC.. Journal of Clinical Oncology. 31(15_suppl). e13529–e13529. 1 indexed citations
6.
7.
Blank, Jonathan L., Katherine Cosmopoulos, David C. Bouck, et al.. (2012). Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924. Cancer Research. 73(1). 225–234. 85 indexed citations
8.
Blackburn, Christopher, Jonathan L. Blank, Frank J. Bruzzese, et al.. (2012). Optimization of a series of dipeptides with a P3 β-neopentyl asparagine residue as non-covalent inhibitors of the chymotrypsin-like activity of human 20S proteasome. MedChemComm. 3(6). 710–719. 9 indexed citations
9.
Liao, Hua, Jonathan L. Blank, David C. Bouck, et al.. (2011). Quantitative Proteomic Analysis of Cellular Protein Modulation upon Inhibition of the NEDD8-Activating Enzyme by MLN4924. Molecular & Cellular Proteomics. 10(11). M111.009183–M111.009183. 58 indexed citations
10.
Kupperman, Erik, Edmund C. Lee, Yueying Cao, et al.. (2010). Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer. Cancer Research. 70(5). 1970–1980. 409 indexed citations
11.
Blackburn, Christopher, Kenneth M. Gigstad, Paul Hales, et al.. (2010). Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit. Biochemical Journal. 430(3). 461–476. 129 indexed citations
12.
Blackburn, Christopher, Jonathan L. Blank, Frank J. Bruzzese, et al.. (2010). Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome. Bioorganic & Medicinal Chemistry Letters. 20(22). 6581–6586. 39 indexed citations
13.
Kupperman, Erik, Edmund Lee, Yueying Cao, et al.. (2009). In-Vitro and in-Vivo Evaluation of the Orally Active Proteasome Inhibitor MLN9708 in Hematological Models of Human Cancer.. Blood. 114(22). 2709–2709. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026